The β2-adrenergic receptor Arg16-Gly polymorphism and interactions involving β2- and β3-adrenergic receptor polymorphisms are associated with variations in longitudinal serum lipid profiles: The Bogalusa Heart Study

Metabolism: Clinical and Experimental

Volumn 53, Issue 9, 2004, Pages 1184-1191

  Hallman, D Michael ^a   Srinivasan, Sathanur R ^b   Chen, Wei ^b   Boerwinkle, Eric ^a,c   Berenson, Gerald S ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GLYCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRYPTOPHAN;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GROWTH CURVE; HOMOZYGOTE; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RACE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ALGORITHMS; AMINO ACID SUBSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL, LDL; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; LIPIDS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 4344659423     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.03.019     Document Type: Article

References (47)

1. Ferrara L.A., Marotta T., Rubba P., et al. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism. Am J Med. 80:(suppl 2A):1986;104-108
2. Rohrer D.K. Physiological consequences of β-adrenergic receptor disruption. J Mol Med. 76:1998;764-772
3. Collins S., Surwit R.S. The β-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res. 56:2001;309-328
4. Arner P., Wahrenberg H., Lönnqvist F., et al. Adipocyte β-adrenoceptor sensitivity influences plasma lipid levels. Arterioscler Thromb. 13:1993;967-972
5. 3- adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol. 117:1996;907-913
6. Hoffstedt J., Arner P., Hellers G., et al. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res. 38:1997;795-804
7. Reynisdottir S., Ellerfeldt K., Wahrenberg H., et al. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest. 93:1994;2590-2599
8. Hellström L., Wahrenberg H., Reynisdottir S., et al. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism. J Clin Endocrinol Metab. 82:1997;159-166
9. Barbe P., Stich V., Galitzky J., et al. In vivo increase in β-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet. J Clin Endocrinol Metab. 82:1997;63-69
10. Hagström-Toft E., Enoksson S., Moberg E., et al. β-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. Am J Physiol. 275:1998;E909-E916
11. 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 42:1999;98-101
12. 2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med. 247:2000;651-656
13. 2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med. 248:2000;239-244
14. 3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism. 49:2000;1063-1070
15. Ukkola O., Pérusse L., Weisnagel S.J., et al. Interactions among the glucocorticoid receptor, lipoprotein lipase, and adrenergic receptor genes and plasma insulin and lipid levels in the Quebec Family Study. Metabolism. 50:2001;246-252
16. 3- adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population Interaction with a common lipoprotein lipase gene variation. J Intern Med. 250:2001;348-360
17. 3-adrenergic receptor gene variant is associated with upper body obesity only in obese Japanese-American men but not in women. Diabetes Res Clin Pract. 54:2001;49-55
18. 3-adrenergic receptor gene. Diabetes. 45:1996;1115-1120
19. 3-adrenergic receptor. No evidence for its association with obesity in Japanese. Arterioscler Thromb Vasc Biol. 18:1998;941-946
20. Manraj M., Francke S., Hébé A., et al. Genetic and environmental nature of the insulin resistance syndrome in Indo-Mauritian subjects with premature coronary heart disease Contribution of β3-adrenoreceptor gene polymorphism and beta blockers on triglyceride and HDL concentrations. Diabetologia. 44:2001;115-122
21. 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens. 17:1999;33-38
22. 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia. 40:1997;469-472
23. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333:1995;348-351
24. 3-adrenoceptor gene to central adiposity and high blood pressure Interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens. 19:2001;399-406
25. Berenson G.S., McMahan C.A., Voors A.W., et al. Cardiovascular Risk Factors in Children. The Early Natural History of Atherosclerosis and Essential Hypertension. 1980;Oxford University Press, New York, NY
26. Lipid Research Clinics Program. Manual of Laboratory Operations. Vol I: Lipid and Lipoprotein Analysis. DHEW Publication No. (NIH) 75-628. 1974;National Institutes of Health, Washington, DC
27. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476-482
28. Allain C.C., Poon L.S., Chan C.S.G., et al. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475
29. Srinivasan S.R., Berenson G.S. Serum lipoproteins in children and methods for study. Lewis L.A., Opplt J.J. CRC Handbook on Electrophoresis. Vol 3. Lipoprotein Methodology and Human Studies. 1983;185-204 CRC Press, Boca Raton, FL
30. Goldstein H., Healy M.J.R., Rasbash J. Multilevel time series models with applications to repeated measures data. Stat Med. 13:1994;1643-1655
31. SAS Institute I. SAS release 8.2. 2001;SAS Institute, Cary, NC
32. 3-adrenergic receptor. Arch Med Res. 30:1999;459-464
33. Mast M., Körtzinger I., König E., et al. Gender differences in fat mass of 5-7-year old children. Int J Obesity. 22:1998;878-884
34. Freedman D.S., Burke G.L., Harsha D.W., et al. Relationship of changes in obesity to serum lipid and lipoprotein changes in childhood and adolescence. JAMA. 254:1985;515-520
35. Horber F.F., Gruber B., Thomi F., et al. Effect of sex and age on bone mass, body composition and fuel metabolism in humans. Nutrition. 13:1997;524-534
36. Trudeau F., Shephard R.J., Arsenault F., et al. Changes in adiposity and body mass index from late childhood to adult life in the Trois-Rivières Study. Am J Human Biol. 13:2001;349-355
37. DeNino W.F., Tchernof A., Dionne I.J., et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 24:2001;925-932
38. Daniels S.R., Khoury P.R., Morrison J.A. The utility of body mass index as a measure of body fatness in children and adolescents Differences by race and gender. Pediatrics. 99:1997;804-807
39. Deurenberg P., Yap M., van Staveren W.A. Body mass index and percent body fat A meta analysis among different ethnic groups. Int J Obesity. 22:1998;1164-1171
40. Huang T.T.-.K, Johnson M.S., Figueroa-Colon R., et al. Growth of visceral fat, subcutaneous abdominal fat, and total body fat in children. Obesity Res. 9:2001;283-289
41. Morrison J.A., Barton B.A., Obarzanek E., et al. Racial differences in the sums of skinfolds and percentage of body fat estimated from impedance in black and white girls, 9 to 19 years of age The National Heart, Lung, and Blood Institute Growth and Health Study. Obesity Res. 9:2001;297-305
42. Prentice A.M., Jebb S.A. Beyond body mass index. Obes Rev. 2:2001;141-147
43. Leibel R.L., Hirsch J. Site- and sex-related differences in adrenoreceptor status of human adipose tissue. J Clin Endocrinol Metab. 64:1987;1205-1210
44. Krone W., Müller-Wieland D., Nägele H., et al. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism. J Cardiovasc Pharm. 10:(suppl 10):1987;S199-S202
45. Rosenbaum M., Presta E., Hirsch J., et al. Regional differences in adrenoreceptor status of adipose tissue in adults and prepubertal children. J Clin Endocrinol Metab. 73:1991;341-347
46. Flechtner-Mors M., Ditschuneit H.H., Yip I., et al. Sympathetic modulation of lipolysis in subcutaneous adipose tissue Effects of gender and energy restriction. J Lab Clin Med. 134:1999;33-41
47. Lonnqvist F., Thorne A., Large V., et al. Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol. 17:1997;1472-1480